4//SEC Filing
Anand Bhaskar 4
Accession 0001599298-25-000036
CIK 0001599298other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:06 PM ET
Size
5.6 KB
Accession
0001599298-25-000036
Insider Transaction Report
Form 4
Anand Bhaskar
Chief Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2025-01-12+75,000→ 75,000 totalExercise: $17.85Exp: 2035-01-12→ Common Stock (75,000 underlying)
Footnotes (2)
- [F1]The option was granted on January 12, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 12, 2026.
- [F2]Not Applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001890784
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:06 PM ET
- Size
- 5.6 KB